CellSave Arabia, the premier private stem cell biobank in the GCC, recently signed an exclusive agreement with HMS Group. This landmark partnership integrates advanced stem cell preservation directly into premium maternity care pathways across Dubai. By combining clinical excellence with advanced biobanking, both organizations actively elevate the standard of newborn healthcare in the region.
Elevating Clinical Standards in Dubai
This collaboration delivers sophisticated, end-to-end medical solutions to expectant families. CellSave Arabia serves as the exclusive provider for comprehensive gestational tissue preservation. This clinical integration ensures seamless continuity of care from the delivery room to the laboratory.
โThis partnership marks a key step in advancing maternal and newborn healthcare standards in Dubai,โ said Alia Abdel Razeq, COO of CellSave Arabia.
Comprehensive Biobanking Services
The exclusive protocol secures vital medical resources for the future. Specialized clinicians manage the advanced preservation of multiple critical newborn stem cell sources:
- Cord Blood and Tissue: Secures foundational hematologic and mesenchymal stem cells.
- Placental and Vessel Tissue: Preserves rich cellular structures for future regenerative therapies.
- Amnion Preservation: Isolates versatile biological material crucial for advanced healing applications.
Mr. Alaa Attari,ย CEOย atย HMSย Group,ย said,ย “We are pleased to partner withย CellSaveย Arabia, a recognized leader in stem cell preservation and regenerative medicine. This collaboration reflects our commitment to providing expectant families with access to advanced healthcare solutions that help secure their future health and well-being. Together, we aim to raise awareness and support parents in making informed decisions throughout their maternity journey.โย
Uncompromised Quality and International Compliance
Safety and international compliance form the bedrock of this medical alliance. CellSave Arabia operates under rigorous global benchmarks, holding prestigious AABB accreditation and adhering strictly to ISO 20387 biobanking practices.
These stringent standard operating procedures guarantee optimal cell viability and ultimate security for long-term storage. Consequently, corporate stakeholders and families receive the highest level of therapeutic assurance.
Empowering Families Through Patient Education
Beyond clinical storage, this corporate alliance prioritizes community health and proactive patient education. The organizations are launching collaborative antenatal sessions and structured healthcare awareness programs. These corporate wellness initiatives provide parents with data-driven insights regarding regenerative medicine. Empowered with medical facts, families confidently make informed choices for their childrenโs long-term well-being.
Visionary Leadership for Future Well-being
This partnership underscores a shared corporate vision to advance the UAE’s healthcare landscape. Leadership from both organizations emphasizes a deep commitment to sustainable medical innovation and preventative family health.
- Securing Futures: Mr. Alaa Attari, CEO at HMS Group, notes that the collaboration provides families access to advanced healthcare solutions.
- Driving Expansion: The agreement accelerates CellSave Arabiaโs market growth as a leader in regional regenerative medicine.
Ultimately, this corporate alliance positions Dubai at the forefront of global biobanking and personalized healthcare.
